MarginsXMarginsX
Home › Markets › Health Care › BCTX

BriaCell Therapeutics Corp. Common Shares (BCTX)

BCTX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.30
-2.65% on the day
Market cap
$28.8M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerBCTX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryCanada
IPO yearNot reported by the screener
SEC CIK0001610820
SEC industry codePharmaceutical Preparations
Incorporated inBC
Canadian listingTSX: BCT

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
4.1 months
$9.9M cash at July 31, 2026
Share count, 1 year
+363.5%
2025-10-15 to 2026-10-28 · +446.4% over 3 years
Going-concern doubt
Yes
10-K filed October 28, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As discussed in Note 1 to the consolidated financial statements, the Company incurred operating losses, negative cash flows from operating activities and has an accumulated deficit that raise substantial doubt about its ability to continue as a going concern."
10-K 2026-10-28
Cash and burn$9.9M cash; operating cash flow -$7.2M a quarter.Report 2026-07-31
Shares outstanding8,732,381 (2026-10-28); 1,883,906 a year earlier; 15,981,726 three years earlier. 3y figure adjusted for splits (1-for-10 overall).Cover page 2026-10-28
Reverse splits, 3 years1; latest 1-for-10 on 2025-08-25Source 2025-08-25
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-06-02
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2026-02-26
AuditorMNP LLP, Toronto, CanadaPCAOB Form AP 2026-10-29
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q4 2026
2026-07-31
Not filed-$12.3M-$6.0M$9.9MNo debt tagsNeeds four quarters10-K 2026-10-28
Q3 2026
2026-04-30
Not filed-$7.2M-$7.0M$6.9MNo debt tagsNeeds four quarters10-Q 2026-06-09
Q2 2026
2026-01-31
Not filed-$7.2M-$8.0M$29.9MNo debt tagsNeeds four quarters10-Q 2026-03-10
Q1 2026
2025-10-31
Not filed-$8.2M-$7.7M$2.7MNo debt tagsNeeds four quarters10-Q 2025-12-11
Q4 2025
2025-07-31
Not filed-$8.1M-$8.1M$10.5MNo debt tagsNeeds four quarters10-K 2026-10-28
Q3 2025
2025-04-30
Not filed-$6.1M-$7.2M$12.5MNo debt tagsNeeds four quarters10-Q 2026-06-09
Q2 2025
2025-01-31
Not filed-$6.3M-$5.9M$5.0MNo debt tagsNeeds four quarters10-Q 2026-03-10
Q1 2025
2024-10-31
Not filed-$5.8M-$7.0M$5.8MNo debt tagsNeeds four quarters10-Q 2025-12-11

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-06-02
Latest annual report10-K2026-10-28
Latest quarterly / interim10-Q2026-06-09
Latest current report8-K2026-06-26
Latest proxyDEF 14A2026-02-12

Source: SEC EDGAR submissions feed, 324 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-14.2%
1 month-8.6%
3 months-1.5%
Year to date-52.3%
1 year-65.2%
From 52-week high-73.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
BCTXLBriaCell Therapeutics Corp. Warrant expiring 2031$0.8200
BCTXZBriaCell Therapeutics Corp. Warrant expiring 2030$0.1149

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
SCYXSCYNEXIS Inc.$2.91-9.35%$29.0M
PMNProMIS Neurosciences Inc. Common Shares (ON)$3.31+0.61%$29.8M
AARDAardvark Therapeutics Inc.$1.26-5.26%$27.6M
NXTCNextCure Inc.$6.68+4.38%$30.6M
RMTIRockwell Medical Inc.$6.76-4.38%$26.9M
NSRXNasus Pharma Ltd.$2.66-7.32%$31.2M
MIRAMIRA Pharmaceuticals Inc.$0.6310-4.38%$26.5M
NNVCNanoViricides Inc.$1.24+0.81%$31.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier